Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil

Cancer Research
Shulin Wang, Wafik S El-Deiry

Abstract

The candidate tumor suppressor KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor for the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a promising agent for cancer therapy. The majority of studies on KILLER/DR5 have been focused on its role in TRAIL-induced apoptosis. However, its contribution to the inhibition of tumor growth and its role as a determinant of chemosensitivity are poorly understood. In the present study, we have generated stable human colon cancer cell lines, in which the function of KILLER/DR5 was ablated using inducible RNA interference. Inducible silencing of KILLER/DR5 in vivo by exposure of mice to doxycycline led to accelerated growth of bioluminescent tumor xenografts and conferred resistance to the chemotherapeutic agent 5-fluorouracil. Our results suggest that KILLER/DR5 may be a critical determinant for tumorigenicity and chemosensitivity.

References

Apr 4, 1997·Science·G PanV M Dixit
Oct 6, 1997·The EMBO Journal·H WalczakC T Rauch
Nov 5, 1997·The Journal of Biological Chemistry·M MacFarlaneE S Alnemri
Nov 5, 1997·Nature Genetics·G S WuW S el-Deiry
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·R R Wallace-Brodeur, S W Lowe
Mar 30, 2001·The Journal of Biological Chemistry·E R McDonaldW S El-Deiry
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Sep 21, 2002·Cancer Cell·Thijn R BrummelkampReuven Agami
Feb 11, 2003·Nature Immunology·Salah-Eddine Lamhamedi-CherradiYouhai H Chen
Nov 25, 2003·Oncogene·Shulin Wang, Wafik S El-Deiry
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shulin Wang, Wafik S El-Deiry
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu

❮ Previous
Next ❯

Citations

May 3, 2005·Cancer Immunology, Immunotherapy : CII·Thomas J Sayers, William J Murphy
Mar 31, 2007·Cancer Chemotherapy and Pharmacology·Karen W Barbour, Franklin G Berger
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·Albert F KaboreSpencer B Gibson
Jan 24, 2013·Applied Biochemistry and Biotechnology·Puthucode Venkatakrishnan Ramachandran, Savarimuthu Ignacimuthu
Aug 25, 2006·Nature Methods·Ola Snøve, John J Rossi
Oct 2, 2007·Nature Reviews. Drug Discovery·Lucia AltucciHinrich Gronemeyer
Nov 8, 2008·Nature Reviews. Drug Discovery·Avi Ashkenazi
Oct 26, 2005·Oncogene·D B LongleyP G Johnston
Sep 2, 2006·Nucleic Acids Research·Sven KappelKlaus Strebhardt
Jun 21, 2005·Molecular and Cellular Biology·Shashirekha ShettySpencer B Gibson
Feb 17, 2005·Molecular and Cellular Biology·Niklas FinnbergWafik S El-Deiry
Jan 26, 2011·PloS One·Christina MenkeAndrew Thorburn
Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Wenge WangWafik S El-Deiry
Sep 8, 2010·Expert Opinion on Therapeutic Targets·Junaid Abdulghani, Wafik S El-Deiry
Oct 4, 2005·FEBS Letters·Mohammed AmarzguiouiDongho Kim
Feb 2, 2016·Journal of Natural Products·Dain ParkSeok-Geun Lee
Jun 5, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Andrew Thorburn
Aug 10, 2011·Cancer Letters·Olivier M Niemoeller, Claus Belka
Dec 5, 2009·Gynecologic Oncology·Evelien W DuikerElisabeth G E de Vries
Apr 28, 2009·Advanced Drug Delivery Reviews·Knut StiegerFabienne Rolling
Dec 17, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Katharina LeithnerHorst Olschewski
Aug 30, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Virginie GranciMarc Ychou
Apr 24, 2007·Advanced Drug Delivery Reviews·Lars Aagaard, John J Rossi
Jul 29, 2009·International Journal of Cancer. Journal International Du Cancer·Eftychia OikonomouAlexander Pintzas
Jan 17, 2012·The EMBO Journal·Ryan E HenryJoaquín M Espinosa
May 4, 2013·British Journal of Pharmacology·O MicheauF Dufour
Jun 21, 2005·Biochemical and Biophysical Research Communications·Mano HorinakaToshiyuki Sakai
Jan 11, 2012·Biochemical Pharmacology·Luis Martinez-LostaoJavier Naval
Dec 21, 2004·Cancer Cell·Peiwen FeiWafik S El-Deiry
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lori S Hart, Wafik S El-Deiry
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Caroline M van GeelenJan J Koornstra
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wafik S El-DeiryGary J Kelloff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Sunita GuptaVivek Mittal
© 2021 Meta ULC. All rights reserved